Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.09 -0.53 (-3.66%)
As of: Oct 22, 2026 · 12:26 PM EDT

Iovance Biotherapeutics (IOVA) Receivables - Other (2011)

Updated

Iovance Biotherapeutics (IOVA) reported Receivables - Other of $50,000 for Q3 2011, unchanged from the prior quarter.

Analysis

Iovance Biotherapeutics (IOVA) Receivables - Other (2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,172.40 Bn 1,140.99 Bn 19.71 Bn
2 Johnson & Johnson 642.90 Bn 561.42 Bn 17.26 Bn
3 AbbVie 502.02 Bn 475.14 Bn 12.70 Bn
4 Merck 375.88 Bn 330.26 Bn 12.21 Bn
5 Novartis Ag 302.81 Bn 266.80 Bn 11.24 Bn
6 Astrazeneca 268.58 Bn 242.27 Bn 12.86 Bn
7 Amgen 242.38 Bn 197.78 Bn 7.24 Bn
8 Gilead Sciences 193.63 Bn 167.83 Bn 6.22 Bn
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn
10 Iovance Biotherapeutics 6.35 Bn 5.14 Bn 55.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 50,000.00
Jun 30, 2011 50,000.00
API Access

Iovance Biotherapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=IOVA&period=max&api_key=YOUR_API_KEY